TETRALOGIC PHARMACEUTICALS CORPORATION Common Stock, par value $0.0001 per share Underwriting AgreementUnderwriting Agreement • May 1st, 2015 • Tetralogic Pharmaceuticals Corp • Pharmaceutical preparations • New York
TetraLogic Pharmaceuticals Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. and Nomura Securities International, Inc. are acting as representatives (the “Representatives” or “you”) an aggregate of 6,250,000 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 937,500 additional shares (the “Optional Securities”) of common stock, par value $0.0001 per share (“Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
